Label Changes for:
Zoloft (sertraline hydrochloride) Tablets and Oral Concentrate
February 2013
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2013
ADVERSE REACTIONS
Other Events Observed During the Post marketing Evaluation
- diabetes mellitus
December 2012
(Serotonin Toxicity associated with co-administration with Linezolid and Methylene Blue)
